Helix BioMedix, ( Nachrichten ) Inc. (OTCBB:HXBM), a developer of bioactive peptides, today announced that it has retained the Shelton Group to serve as its strategic investor relations counsel.
From: www.finanznachrichten.de
Helix BioMedix Retains Shelton Group as its Investor Relations Agency
Posted by Ruslan Abuzant at 8:26 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment